Simplex Trading’s Aegerion Pharmaceuticals AEGR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-93
Closed -$1K 6823
2015
Q4
$1K Buy
+93
New +$1.12K ﹤0.01% 5201
2015
Q3
Sell
-35
Closed -$2K 6714
2015
Q2
$2K Sell
35
-6
-15% -$130 ﹤0.01% 4485
2015
Q1
$14K Sell
41
-36
-47% -$916 ﹤0.01% 2664
2014
Q4
$10K Buy
+77
New +$1.94K ﹤0.01% 2625

Simplex Trading's AEGR Position: Q4 2016 in Review

Simplex Trading sold out of Aegerion Pharmaceuticals (AEGR) in Q4 2016, closing a stake of 6,820 shares — an estimated $20K sold.

Simplex Trading first reported a position in AEGR in Q4 2014 and held it in 6 quarters. The position peaked at $308K in Q4 2014. 0 funds tracked by Wall St. Rank hold AEGR as of Q4 2016.

  • Simplex Trading reported no remaining Aegerion Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
  • Simplex Trading sold 6,820 Aegerion Pharmaceuticals shares in Q4 2016, an estimated $20K.
  • Simplex Trading first reported a position in Aegerion Pharmaceuticals in Q4 2014 and held it in 6 quarters.
  • Simplex Trading's Aegerion Pharmaceuticals position peaked at $308K in Q4 2014.
  • 0 funds tracked by Wall St. Rank held Aegerion Pharmaceuticals as of Q4 2016.

Based on Simplex Trading's 13F filing for Q4 2016, filed 11 Jan 2017.